series-c-plus
Stage
1
Investors
About
MAG-LAB provides NMR spectroscopy services combined with custom stable-isotope labeling of proteins and ligands to map and characterize protein–ligand interactions at atomic resolution, supporting hit-to-lead and lead optimization in drug discovery. They supply labeled precursors and offer protein expression/labeling, fragment screening, binding-site mapping and solution-structure analysis including intrinsically disordered proteins.
Explore MAG-LAB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.